PML and cancer: In the context of cancer, meanwhile, TRIM19 has been implicated in the clearance of misfolded proteins as part of a pro-tumourigenic anti-oxidant response, in accordance with its role as an oncogenic driver as part of the TRIM19/RARα fusion protein (Chen et al., 2017).